Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley purchased 27 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were acquired at an average price of GBX 1,451 ($18.33) per share, for a total transaction of £391.77 ($494.97).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley purchased 7,407 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,343 ($16.97) per share, for a total transaction of £99,476.01 ($125,680.37).
Johnson Matthey Stock Up 1.0 %
JMAT stock opened at GBX 1,463.22 ($18.49) on Friday. The company’s 50 day moving average price is GBX 1,384.37 and its 200 day moving average price is GBX 1,478.99. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a fifty-two week low of GBX 1,295.54 ($16.37) and a fifty-two week high of GBX 1,917.07 ($24.22). The firm has a market capitalization of £2.45 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, February 4th. Investors of record on Thursday, December 5th were paid a dividend of GBX 22 ($0.28) per share. The ex-dividend date of this dividend was Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s payout ratio is 130.84%.
Analysts Set New Price Targets
JMAT has been the topic of a number of recent research reports. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Johnson Matthey in a research note on Tuesday, December 17th. Berenberg Bank cut their price target on shares of Johnson Matthey from GBX 1,650 ($20.85) to GBX 1,500 ($18.95) and set a “hold” rating on the stock in a research note on Thursday, November 28th.
Read Our Latest Analysis on JMAT
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- What is the Nikkei 225 index?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- The 3 Best Blue-Chip Stocks to Buy Now
- DuPont’s Electronics Spinoff: The Start of Something Big
- Most active stocks: Dollar volume vs share volume
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.